We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Stephen Harrison

Stephen A. Harrison MD

Professor of Medicine, Uniformed Services, University of the Health Sciences, Bethesda, Maryland

Stephen A. Harrison, MD graduated from the University of Mississippi School of Medicine. He completed his internal medicine residency and gastroenterology fellowship at Brooke Army Medical Center followed by a 4th year advanced liver disease fellowship at Saint Louis University.  He is board certified in Internal Medicine and Gastroenterology/Hepatology. In addition, he is Professor of Medicine at the Uniformed Services University of the Health Sciences. He is an Associate Editor for Hepatology, a peer-reviewer for 19 medical journals, and is internationally known for studies in Hepatitis C and Non-Alcoholic Fatty Liver Disease where he has published more than 130 peer reviewed papers.

Disclosures

Dr. Harrison is on the advisory board for Nimbus Discovery, Fibrogen, NGM Biopharmaceuticals, Gilead, Intercept, Genfit and Galectin Pharmaceuticals.